上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics Again Selected as Constituent of FTSE4Good Index Series 2022-08-17 10:12
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore 2022-07-19 18:03
WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority 2022-07-12 16:00
WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates 2022-07-08 09:27
WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products 2022-07-05 08:30
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes 2022-06-06 08:30
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability 2022-04-28 08:30
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC 2022-04-15 09:03
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
WuXi Biologics Statement 2022-02-08 11:08
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility 2022-01-18 10:50
WuXi Biologics Launches a New GMP Commercial Drug Product Facility 2021-11-01 10:19
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date 2021-09-01 14:12
WuXi Biologics Reports Strong 2021 Interim Results 2021-08-23 20:59
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate 2021-08-02 20:13
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility 2021-07-26 18:00
WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates 2021-06-10 08:30
1 2 3 4 5 9